| First Author | Zhang Q | Year | 2022 |
| Journal | JCI Insight | Volume | 7 |
| Issue | 3 | PubMed ID | 35132955 |
| Mgi Jnum | J:343955 | Mgi Id | MGI:6884999 |
| Doi | 10.1172/jci.insight.153768 | Citation | Zhang Q, et al. (2022) Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesis. JCI Insight 7(3):e153768 |
| abstractText | Mosaic loss of chromosome Y (mLOY) in blood cells is one of the most frequent chromosome alterations in adult males. It is strongly associated with clonal hematopoiesis, hematopoietic malignancies, and other hematopoietic and nonhematopoietic diseases. However, whether there is a causal relationship between mLOY and human diseases is unknown. Here, we generated mLOY in murine hematopoietic stem and progenitor cells (HSPCs) with CRISPR/Cas9 genome editing. We found that mLOY led to dramatically increased DNA damage in HSPCs. Interestingly, HSPCs with mLOY displayed significantly enhanced reconstitution capacity and gave rise to clonal hematopoiesis in vivo. mLOY, which is associated with AML1-ETO translocation and p53 defects in patients with acute myeloid leukemia (AML), promoted AML in mice. Mechanistically, loss of KDM5D, a chromosome Y-specific histone 3 lysine 4 demethylase in both humans and mice, partially recapitulated mLOY in DNA damage and leukemogenesis. Thus, our study validates mLOY as a functional driver for clonal hematopoiesis and leukemogenesis. |
